AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
30.72
+0.67 (2.23%)
Dec 20, 2024, 4:00 PM EST - Market closed
AtriCure Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for AtriCure stock have an average target of 41.78, with a low estimate of 26 and a high estimate of 61. The average target predicts an increase of 36.00% from the current stock price of 30.72.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AtriCure stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Initiates $40 | Buy | Initiates | $40 | +30.21% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $53 → $61 | Strong Buy | Maintains | $53 → $61 | +98.57% | Dec 9, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $49 → $53 | Strong Buy | Maintains | $49 → $53 | +72.53% | Oct 30, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $32 → $36 | Buy | Maintains | $32 → $36 | +17.19% | Oct 30, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $30 → $40 | Buy | Maintains | $30 → $40 | +30.21% | Oct 30, 2024 |
Financial Forecast
Revenue This Year
470.11M
from 399.25M
Increased by 17.75%
Revenue Next Year
533.27M
from 470.11M
Increased by 13.44%
EPS This Year
-0.86
from -0.66
EPS Next Year
-0.65
from -0.86
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 485.1M | 555.4M | 642.5M | |||
| Avg | 470.1M | 533.3M | 601.0M | |||
| Low | 451.1M | 507.8M | 564.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 21.5% | 18.2% | 20.5% | |||
| Avg | 17.7% | 13.4% | 12.7% | |||
| Low | 13.0% | 8.0% | 5.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.75 | -0.58 | -0.36 | |||
| Avg | -0.86 | -0.65 | -0.44 | |||
| Low | -1.02 | -0.67 | -0.54 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.